Funder
Pharmaceutical Research and Manufacturers of America Foundation
Pharmaceutical Research and Manufacturers of America
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Lortet-Tieulent J, Soerjomataram I, López-Campos JL, Coebergh JW, Ancochea J, Soriano JB. International trends in COPD mortality, 1995–2017. Eur Respir J. 2019;54(6):1901791. https://doi.org/10.1183/13993003.01791-2019.
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2015. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Apr2.pdf. Accessed 11 Jan 2020.
3. Zafari Z, Bryan S, Sin DD, Conte T, Khakban R, Sadatsafavi M. A systematic review of health economics simulation models of chronic obstructive pulmonary disease. Value Health. 2017;20(1):152–62. https://doi.org/10.1016/j.jval.2016.08.003.
4. Gray C, Slejko JF. Identifying COPD patient-informed value elements in economic evaluations: a systematic review. Value Health. 2019;22:S361. https://doi.org/10.1016/j.jval.2019.04.1767.
5. Bereza BG, Nielsen AT, Valgardsson S, Hemels MEH, Einarson TR. Patient preferences in severe COPD and asthma: a comprehensive literature review. Int J Chron Obstruct Pulmon Dis. 2015;10:739–44. https://doi.org/10.2147/COPD.S82179.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献